Örebro University Hospital
Welcome,         Profile    Billing    Logout  
 72 Trials 
33 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Szabo, Eva
NCT03978000 / 2018-000754-22: IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

Active, not recruiting
3
2158
Europe, US, RoW
IBP-9414, Placebo
Infant Bacterial Therapeutics
Necrotizing Enterocolitis
06/24
07/24
Linde, Peter
NCT05891366: Single Ascending Dose Study of WAL0921 in Healthy Subjects

Completed
1
40
US
WAL0921, Placebo
Walden Biosciences
Healthy
01/24
01/24
Andersson, Tommy
EXCELLENT, NCT03685578: CERENOVUS Neurothrombectomy Devices Registry

Recruiting
N/A
2000
Europe, US, RoW
EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter, CEREGLIDE 71 Intermediate Catheter
Cerenovus, Part of DePuy Synthes Products, Inc.
Cerebral Stroke
03/25
06/25
EXCELLENT, NCT05591183: CERENOVUS Neurothrombectomy Devices Registry

Recruiting
N/A
2000
Europe, US, RoW
EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter
Cerenovus, Part of DePuy Synthes Products, Inc.
Cerebral Stroke
07/24
10/24
Christiansen, Evald H
OCT SORT-OUT, NCT02253108: The VIII Study

Active, not recruiting
N/A
160
Europe
Everolimus eluting bioresorbable polymer stent, SYNERGY, Biolimus eluting bioresorbable polymer stent, Biomatrix NeoFlex
Aarhus University Hospital Skejby, Biosensors International, Boston Scientific Corporation
Coronary Artery Disease, Angina Pectoris, Myocardial Infarction
04/15
12/25
NOTION-2, NCT02825134: Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis

Active, not recruiting
N/A
376
Europe, RoW
Transcatheter aortic valve replacement, Transcatheter aortic valve implantation, TAVR, TAVI, Surgical aortic valve replacement, SAVR
Ole De Backer, Symetis SA, Boston Scientific Corporation, Abbott, Edwards Lifesciences
Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases, Heart Valve Diseases, Ventricular Outflow Obstruction
02/24
06/29
OCTOBER, NCT03171311: The Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction

Active, not recruiting
N/A
1201
Europe
Angiographic guided PCI, PCI, percutaneous transluminal coronary angioplasty (PTCA), OCT guided PCI, OCT
Aarhus University Hospital Skejby, Abbott
Ischaemic Heart Disease, Ischemic Heart Disease
03/22
05/29
SORTOUTXI, NCT03952273: Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

Active, not recruiting
N/A
3141
Europe
PCI with BioMatrix Alpha™ stent, Biolimus eluting absorbable polymer coated BioMatrix Alpha™ stent, PCI with Combo™ stent, Combined sirolimus eluting and endothelial progenitor cell Combo™ stent
Phillip Freeman, Aarhus University Hospital, Odense University Hospital, OrbusNeich, Biosensors International
Coronary Artery Disease
03/23
11/30
BALI, NCT04253171: Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions

Active, not recruiting
N/A
200
Europe
Lithoplasty, Shockwave, Lithotripsy, Conventional
Herlev and Gentofte Hospital, Abbott
Percutaneous Coronary Intervention, Coronary Artery Calcification, Coronary Artery Disease
09/25
01/27
Fröbert, Ole
NCT04562805: Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

Active, not recruiting
N/A
2400
Europe
DynamX Bioadaptor, Resolute Onyx
Elixir Medical Corporation, Uppsala University
Coronary Artery Disease, Ischemic Heart Disease
08/24
07/28
Gupta, Anil
NCT06261957: A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma

Recruiting
3
412
Europe, Canada, US, RoW
Salbutamol HFA-134a, Salbutamol HFA-152a
GlaxoSmithKline
Asthma
04/25
04/25
SURMOUNT-5, NCT05822830: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

Active, not recruiting
3
700
US
Tirzepatide, LY3298176, Semaglutide
Eli Lilly and Company
Obesity, Overweight
11/24
11/24
BRAIN-AF, NCT02387229: Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

Terminated
3
1238
Canada
Rivaroxaban, Xarelto, standard of care
Montreal Heart Institute, Canadian Stroke Prevention Intervention Network, The Montreal Health Innovations Coordinating Center (MHICC), Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma, Montreal Heart Institute Foundation, Canadian Institutes of Health Research (CIHR), Hewitt Foundation
ATRIAL FIBRILLATION
05/24
05/24
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Active, not recruiting
3
15374
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/27
10/27
NCT05891834: Study of INV-202 in Patients With Obesity and Metabolic Syndrome

Active, not recruiting
2
243
Canada
INV-202, Placebo
Inversago Pharma Inc.
Obesity, Metabolic Syndrome
07/24
03/25
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis Pain

Recruiting
2
420
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain
07/25
10/25
NCT05936151: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Recruiting
2
120
Europe, Canada, US
LY3437943, Placebo
Eli Lilly and Company
Overweight or Obesity, CKD, Type 2 Diabetes
11/25
11/25
NCT01191151: Web Based Orthopaedic Sports Medicine Registry

Recruiting
N/A
12500
Europe, Canada, US, RoW
Arthrex, Inc.
Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist, Degenerative and Traumatic Pathology of the Hip
06/23
06/23
Jendle, Johan
NCT05029271: InPen User Experience

Completed
N/A
34
Europe
InPen with Guardian 4 System
Medtronic Diabetes
Diabetes Type 1
12/23
12/23
Torsello, Giovanni
INSIGHT, NCT02477111: European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms

Completed
N/A
150
Europe
Endovascular abdominal aortic aneurysm repair
Cordis Corporation
Abdominal Aortic Aneurysms
10/16
12/21
EMINENT, NCT02921230: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery

Active, not recruiting
N/A
775
Europe
Peripheral stenting
Boston Scientific Corporation
Arterial Occlusive Diseases, Atherosclerosis, Vascular Diseases, Arteriosclerosis
07/21
04/25
SOCRATES, NCT04503395: ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR:

Recruiting
N/A
204
Europe
ESAR treatment: Endograft + Heli-FX Endoanchor, FEVAR treatment : Fenestrated endograft
FCRE (Foundation for Cardiovascular Research and Education), Medtronic
Aortic Aneurysm, Abdominal
06/26
06/28
TiGER, NCT04246463: Terumo Aortic Global Endovascular Registry

Recruiting
N/A
1000
Europe, US
Thoracic, Abdominal, Custom Device, Illiac Artery
Vascutek Ltd., Bolton Medical
Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
11/29
11/30
Savilampi, Johanna
NCT04885491: A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension

Withdrawn
1/2
16
Europe
Sodium chloride (placebo), NaCl, PDNO, Nitrosooxypropanol
Attgeno AB, Vinnova
Pulmonary Hypertension, COVID-19
04/23
04/23
Ahlstrand, Erik
NCT04307576 / 2018-001795-38: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
3
6430
Europe, RoW
Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto
Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins
Leukemia, Acute Lymphoblastic
06/27
06/32
Sundh, Josefin
NCT04896853: Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Recruiting
1
9
Europe
ProTrans®
NextCell Pharma Ab, Karolinska Trial Alliance
COVID-19 Acute Respiratory Distress Syndrome, Influenza A, Metapneumovirus Pneumonia, Respiratory Syncytial Virus (RSV)
09/24
12/24
HILOT, NCT06247397: Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

Recruiting
N/A
310
Europe
Added high-flow oxygen therapy, Standard care
Skane University Hospital, Uppsala University Hospital, Region Stockholm, Region Örebro County, Blekinge County Council Hospital, Blekinge Institute of Technology, Lund University, Region Östergötland, Vastra Gotaland Region, Region Västerbotten, Landstinget i Värmland, ResMed, Swedish Heart Lung Foundation, The Swedish Research Council
Chronic Obstructive Pulmonary Disease Severe, Interstitial Lung Disease, Chronic Respiratory Failure With Hypoxia
12/27
12/28
Adjedj, Julien
CALIPSO, NCT05301218: CAlcified Lesion Intervention Planning Steered by OCT.

Recruiting
N/A
140
Europe
angioplasty
Institut Mutualiste Montsouris, Abbott
Coronary Artery Calcification, Angioplasty
12/23
12/23
LEVIN, Mark-David
DREAMM 5, NCT04126200 / 2019-001138-32: Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Hourglass Jul 2021 - Dec 2021 : From DREAMM-5 trial in combination with nirogacestat for r/r multiple myeloma
Hourglass Feb 2020 - Mar 2020 : Initiation of P1b sub-study of P2 DREAMM-5 trial in combination with nirogacestat for relapsed/refractory multiple myeloma
Checkmark From DREAMM 5 trial in R/R multiple myeloma patients at ASH 2019
Nov 2019 - Nov 2019: From DREAMM 5 trial in R/R multiple myeloma patients at ASH 2019
Checkmark Initiation of DREAMM-5 trial in r/r multiple myeloma
More
Recruiting
1/2
464
Europe, Canada, Japan, US, RoW
Belantamab mafodotin, GSK3174998, Feladilimab, Nirogacestat, Dostarlimab, Isatuximab, Lenalidomide, Dexamethasone, Pomalidomide
GlaxoSmithKline
Multiple Myeloma
02/26
02/29
IONA-MM, NCT04458831: A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Recruiting
N/A
1200
Europe, Japan, US, RoW
isatuximab SAR650984, Sarclisa, Pomalidomide, Pomalyst, Dexamethasone, Carfilzomib
Sanofi
Plasma Cell Myeloma
02/26
02/26
Valachis, Antonios
postMONARCH, NCT05169567 / 2021-002301-10: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

Active, not recruiting
3
368
Europe, US, RoW
Abemaciclib, Fulvestrant, Placebo
Eli Lilly and Company, Eli Lilly and Company
Breast Neoplasm, Neoplasm Metastasis
02/24
02/26
ASCAPE, NCT04879563: Artificial Intelligence Supporting CAncer Patients Across Europe - the Project

Active, not recruiting
2
500
Europe
ASCAPE-based follow-up strategy
Region Örebro County, UBITECH, ATOS, Siemens Corporation, Corporate Technology, Intrasoft, University of Patras, FORTH - Foundation for Research and Technology Hellas, Sphynx Technology Solutions AG, Faculty of Sciences, University of Novi Sad, Serbia, DFKI - German Research Center for Artificial Intelligence, CareAcross, National and Kapodistrian University of Athens, Greece, Fundacio Clinic Barcelona, Arthur's Legal, Fundacion iSYS
Breast Cancer, Prostate Cancer, Quality of Life, Survivorship, Toxicity
06/24
06/24
Hildén, Karin
IMPACT, NCT03831490: Study for Improving Maternal, Pregnancy and Child Outcomes

Completed
N/A
13000
Europe
history, mean material blod pressure, PlGF - blood sample, a- uterine doppler
Uppsala University, Thermo Fisher Scientific, Inc, Perkin Elmer Inc., Roche Pharma AG
Pre-Eclampsia
12/22
12/22
Jerlsström, Tomas
No trials found
Kättström, Magdalena
No trials found
Ohlsson-Nevo, Emma
No trials found
Rosdahl, Anja
No trials found
Joelson, Anders
No trials found
Ingberg, Edvin
No trials found
Kaettstroem, Magdalena
No trials found
Kattström, Magdalena
No trials found
Kirrander, Peter
No trials found
Saber, Amanj
No trials found
Hellkvist, Laila
No trials found
Cajander, Sara
No trials found
Hospital, Örebro U
No trials found

Download Options